Service evaluation of preoperative discontinuation of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor subtype 1 antagonists (ARA) and the incidence of intraoperative hypotension

被引:0
|
作者
Cheers, L. [1 ]
Howell, S. [1 ]
机构
[1] Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
18
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [21] Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers
    Weir, MR
    Henrich, WL
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (04): : 403 - 411
  • [22] Interrupting the renin-angiotensin system: The role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension
    Weber, MA
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (12) : 189S - 194S
  • [23] Angiotensin-Converting Enzyme Inhibitors, AG Receptor Blockers, and Aldosterone Receptor Antagonists
    Park, Kyung W.
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 2005, 43 (02) : 23 - 37
  • [24] Diuretics are necessary for optimal renoprotection of angiotensin-converting enzyme (ACEI) or Angiotensin II receptor blocker (ARB).
    Nakao, NN
    Yoshimura, A
    Morita, H
    Inui, K
    Ideura, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 243A - 243A
  • [25] Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists
    Balit, Corrine R.
    Gilmore, Simon P.
    Isbister, Geoffrey K.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2007, 43 (10) : 686 - 688
  • [26] Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI)
    Shiffermiller, Jason F.
    Monson, Benjamin J.
    Vokoun, Chad W.
    Beachy, Micah W.
    Smith, Michael P.
    Sullivan, James N.
    Vasey, Andrew J.
    Guda, Purnima
    Lyden, Elizabeth R.
    Ellis, Sheila J.
    Pang, Huiling
    Thompson, Rachel E.
    JOURNAL OF HOSPITAL MEDICINE, 2018, 13 (10) : 661 - 667
  • [27] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [28] Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice
    Takai, S
    Song, K
    Tanaka, O
    Okunishi, H
    Miyazaki, M
    LIFE SCIENCES, 1996, 59 (21) : PL331 - PL336
  • [29] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport
    Coronel, Francisco
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 136 - 137
  • [30] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Sepetavc, Filip
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (04) : 396 - 408